HOLOGIC INC Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary
Hologic Inc quarterly/annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from Q4 2020 to Q2 2024.
  • Hologic Inc Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending June 29, 2024 was $241M, a 1889% increase year-over-year.
  • Hologic Inc Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending June 29, 2024 was $789M, a 17.1% increase year-over-year.
  • Hologic Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2023 was $676M, a 57.4% decline from 2022.
  • Hologic Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was $1.59B, a 32.7% decline from 2021.
  • Hologic Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2021 was $2.36B, a 136% increase from 2020.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $789M $241M +$229M +1889% Mar 31, 2024 Jun 29, 2024 10-Q 2024-07-30
Q1 2024 $561M $212M -$67.8M -24.3% Dec 31, 2023 Mar 30, 2024 10-Q 2024-05-03
Q4 2023 $628M $191M -$47.8M -20% Oct 1, 2023 Dec 30, 2023 10-Q 2024-02-02
Q3 2023 $676M $146M +$2.1M +1.46% Jul 2, 2023 Sep 30, 2023 10-K 2023-11-21
Q2 2023 $674M $12.1M -$236M -95.1% Apr 2, 2023 Jul 1, 2023 10-Q 2024-07-30
Q1 2023 $910M $279M -$295M -51.4% Jan 1, 2023 Apr 1, 2023 10-Q 2024-05-03
Q4 2022 $1.21B $239M -$383M -61.6% Sep 25, 2022 Dec 31, 2022 10-Q 2024-02-02
Q3 2022 $1.59B $144M -$267M -65.1% Jun 26, 2022 Sep 24, 2022 10-K 2023-11-21
Q2 2022 $1.86B $248M -$89.1M -26.4% Mar 27, 2022 Jun 25, 2022 10-Q 2023-08-01
Q1 2022 $1.94B $574M -$206M -26.4% Dec 26, 2021 Mar 26, 2022 10-Q 2023-05-02
Q4 2021 $2.15B $622M -$211M -25.3% Sep 26, 2021 Dec 25, 2021 10-Q 2023-02-01
Q3 2021 $2.36B $411M Jun 27, 2021 Sep 25, 2021 10-K 2023-11-21
Q2 2021 $338M Mar 28, 2021 Jun 26, 2021 10-Q 2022-07-27
Q1 2021 $781M Dec 27, 2020 Mar 27, 2021 10-Q 2022-04-27
Q4 2020 $832M Sep 27, 2020 Dec 26, 2020 10-Q 2022-02-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.